Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers (2014)
- Authors:
- USP affiliated authors: LAURETTI, GABRIELA ROCHA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1111/jphp.12255
- Subjects: DIABETES MELLITUS; FARMACOCINÉTICA; ANALGÉSICOS; DOR; NEUROPATIAS DIABÉTICAS
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2014
- Source:
- Título: Journal of Pharmacy and Pharmacology
- ISSN: 0022-3573
- Volume/Número/Paginação/Ano: v. 66, n. 9, p. 1222–1230, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
MORAES, Natália Valadares de e LAURETTI, Gabriela Rocha e LANCHOTE, Vera Lúcia. Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers. Journal of Pharmacy and Pharmacology, v. 66, n. 9, p. 1222–1230, 2014Tradução . . Disponível em: https://doi.org/10.1111/jphp.12255. Acesso em: 28 dez. 2025. -
APA
Moraes, N. V. de, Lauretti, G. R., & Lanchote, V. L. (2014). Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers. Journal of Pharmacy and Pharmacology, 66( 9), 1222–1230. doi:10.1111/jphp.12255 -
NLM
Moraes NV de, Lauretti GR, Lanchote VL. Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers [Internet]. Journal of Pharmacy and Pharmacology. 2014 ; 66( 9): 1222–1230.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1111/jphp.12255 -
Vancouver
Moraes NV de, Lauretti GR, Lanchote VL. Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers [Internet]. Journal of Pharmacy and Pharmacology. 2014 ; 66( 9): 1222–1230.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1111/jphp.12255 - In vivo activity of CYP2D6 and enantioselective tramadol clearance in patients with neuropathic pain
- Analysis of rocuronium in human plasma by liquid chromatography–tandem mass spectrometry with application in clinical pharmacokinetics
- Enantioselective analysis of unbound tramadol, O-desmethyltramadol and N-desmethyltramadol in plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetics
- The clinical and laboratorial evaluation of transdermal fentanyl, ketamine, clonidine, or their combination in chronic neuropathic pain
- Transdermal racemic versus transdermal s(+)-ketamine as adjuvant for postoperative analgesia following orthopedic surgery
- Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain
- Transdermal racemic ketamine versus transdermal s(+)-ketamine as adjuvantsa for postoperative analgesia following orthopedic surgery under spinal anesthesia
- Tratamento multimodal da dor neoplásica em estado incicial e avançado
- Efeito antinociceptivo da neostigmina e interacao da neostigmina com a morfina administrada por via intratecal no homem
- Activity of opioid analgesics in seizure models utilizing n-methyl-dl-aspartic acid, kainic acid, bicuculline and pentylene-tetrazole
Informações sobre o DOI: 10.1111/jphp.12255 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
